Company Information

Revenue, expenses and profitability over five years.

Income Statement

BHARAT PARENTERALS LTD.

NSE Code: BPLPHARMAEQ
BSE Code: 541096
ISIN: INE365Y01019
Industry: Pharmaceuticals

Financial Data

Income Statement

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Five-year standalone Income Statement for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	231.66	299.30	253.76	217.50	211.64
Other Operating Revenues	2.36	4.84	0.40	0.48	0.38
Total Operating Revenues	234.01	304.13	254.16	217.98	212.01

Other Income	12.55	14.55	11.96	18.84	7.78
Total Revenue	246.57	318.68	266.11	236.82	219.79

EXPENSES
Cost Of Materials Consumed	148.90	178.34	173.17	146.07	132.72
Purchase Of Stock-In Trade	1.00	1.13	0.41	1.16	1.66
Changes In Inventories Of FG,WIP And Stock-In Trade	2.05	10.14	-15.19	-9.75	1.68
Employee Benefit Expenses	25.13	21.38	19.61	16.93	15.26
Finance Costs	3.44	4.79	3.19	2.19	0.89
Depreciation And Amortisation Expenses	8.36	7.05	6.40	5.85	6.66
Other Expenses	35.84	59.55	47.73	42.20	32.55
Total Expenses	224.72	282.37	235.31	204.65	191.42

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	21.84	36.32	30.80	32.17	28.37

Profit/Loss Before Tax	21.84	36.32	30.80	32.17	28.37

Tax Expenses-Continued Operations
Current Tax	6.60	10.08	8.69	8.40	8.30
Deferred Tax	-1.13	-0.72	-0.45	-0.57	-0.94
Tax For Earlier Years	0.35	0.50	-0.03	0.00	-0.29
Total Tax Expenses	5.82	9.86	8.21	7.83	7.06
Profit/Loss After Tax And Before ExtraOrdinary Items	16.02	26.45	22.59	24.34	21.30

Profit/Loss From Continuing Operations	16.02	26.45	22.59	24.34	21.30

Profit/Loss For The Period	16.02	26.45	22.59	24.34	21.30

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	23.24	40.36	38.81	42.14	37.11
Diluted EPS (Rs.)	23.24	40.36	38.81	42.14	37.11

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.69	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	10.00	10.00	10.00	7.50	0.00

Five-year consolidated Income Statement for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	343.05	335.48	256.96	217.98	211.64
Other Operating Revenues	2.38	4.91	0.40	0.00	0.38
Total Operating Revenues	345.43	340.38	257.36	217.98	212.01

Other Income	9.54	11.62	8.59	11.74	7.78
Total Revenue	354.98	352.00	265.95	229.72	219.79

EXPENSES
Cost Of Materials Consumed	169.26	178.17	173.17	146.07	132.72
Purchase Of Stock-In Trade	17.41	7.76	0.38	1.16	1.66
Changes In Inventories Of FG,WIP And Stock-In Trade	4.73	-0.45	-15.19	-9.75	1.68
Employee Benefit Expenses	67.28	49.66	22.78	18.00	15.37
Finance Costs	12.53	12.95	3.22	2.19	0.89
Depreciation And Amortisation Expenses	34.25	35.32	9.02	5.88	6.66
Other Expenses	70.94	102.54	53.85	42.62	32.93
Total Expenses	376.40	385.95	247.23	206.17	191.92

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	-21.42	-33.95	18.72	23.55	27.88

Profit/Loss Before Tax	-21.42	-33.95	18.72	23.55	27.88

Tax Expenses-Continued Operations
Current Tax	6.89	10.08	8.69	8.40	8.30
Deferred Tax	-1.36	-0.86	-0.45	-0.56	-0.94
Tax For Earlier Years	0.35	0.50	-0.03	0.00	-0.29
Total Tax Expenses	5.88	9.72	8.21	7.84	7.06
Profit/Loss After Tax And Before ExtraOrdinary Items	-27.31	-43.68	10.51	15.71	20.81

Profit/Loss From Continuing Operations	-27.31	-43.68	10.51	15.71	20.81

Profit/Loss For The Period	-27.31	-43.68	10.51	15.71	20.81

Minority Interest	19.12	31.05	4.00	0.73	0.24
Consolidated Profit/Loss After MI And Associates	-8.19	-12.63	14.52	16.44	21.05

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	-39.62	-66.64	24.94	28.40	36.67
Diluted EPS (Rs.)	-39.62	-66.64	24.94	28.40	36.67

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.69	0.58	0.00	0.00	0.00

Source: Financial statements as reported by the company.